Abstract

Calcium Acetate 667-mg Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2013 - Volume 17, Number 3

Page(s): 229

Download in electronic PDF format for $75

Abstract

A formulation for preparing Calcium Acetate 667-mg Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2013 Pg. 229	Calcium Acetate 667-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Nov/Dec 2013 Pg. 501	Cortisone Acetate 25-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 1999 Pg. 415-420	Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II Author(s): Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
Jul/Aug 1999 Pg. 291-294	The Basics of Compounding: Compounding Special Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 306-310	Capsule and Tablet Diluents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 276-278	Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Author(s): Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2022 Pg. 436-439	Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease Author(s): Kobayashi Shunsuke, Ogawara Yuka, Imamura Yoshihiko, Kitaoka Akira, Yasu Takeo
Mar/Apr 2008 Pg. 163-169	Pharmaceutical Development of Enteric-Release Hard Gelatin Capsules in the Compounding Setting Author(s): de Oliveira Ferreira Anderson, Holandino Carla
Sep/Oct 2001 Pg. 401-405	Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Sep/Oct 2018 Pg. 433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Author(s): Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2013 Pg. 230	Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 52	Mupirocin Calcium 2% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 53	Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 75	Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 70	Calcium Chloride 10% Injection Author(s): Allen Loyd V Jr